新型接头蛋白XB130在恶性肿瘤中的研究进展

doi:10.11904/j.issn.1002-3070.2015.06.019

Abstract

Abstract: Currently,XB130 as a newly discovered characterized adaptor protein,it has been implicated as a substrate and regulator of many intracellular signal transduction,such as FAK/SRC,PI3K/Akt and MEK-ERK signaling and so on.It has been found that XB130 is high expression in many cell lines,for instance thyroid carcinoma,osteosarcoma,gastric cancer,esophageal cancer and breast cancer etc.The mechanism of XB130 in tumor is becoming increasingly attention.XB130 is recently attributed to be a new oncogene,and plays important roles in cell pro-liferation,cell survival and tumorigenesis.A deeper understanding of these mechanisms may lead to the discovery of XB130 as an important mediator in tumor development and as a novel therapeutic target for cancer.

Key words: Adaptor protein, XB130, Cancer

CLC Number:

MA Ming, YANG Fang, CHEN Gongyan. Research of XB130,a novel adaptor protein in cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(6): 565-568.

References

1 Shiozaki A,Liu M.Roles of XB130,a novel adaptor protein,in cancer[J].J Clin Bioinforma,2011,1(1):10-14.
2 Zhang J,Park SI,Artime MC,et al.AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts[J].J Clin Invest,2007,117(10):2962-2973.
3 Shiozaki A,Kosuga T,Ichikawa D,et al.XB130 as an independent prognostic factor in human esophageal squamous cell carcinoma[J].Ann Surg Oncol,2013,20(9):3140-3150.
4 Lodyga M,Bai XH,Kapus A,et al.Adaptor protein XB130 is a Rac-controlled component of lamellipodia that regulates cell motility and invasion[J].J Cell Sci,2010,123(23):4156-4169.
5 Liu X,Cai H,Huang H,et al.The prognostic significance of apoptosis-related biological markers in Chinese gastric cancer patients[J].PLoS One,2011,6(12):e29670.
6 Xu JD,Furuya T,Cao XX,et al.Loss of BCL2L10 protein expression as prognostic predictor for poor clinical outcome in gastric carcinoma[J].Histopathology,2010,57(6):814-824.
7 Shiozaki A,Lodyga M,Bai XH,et al.XB130,a novel adaptor protein,promotes thyroid tumor growth[J].Am J Pathol,2011,178(1):391-401.
8 Wang X,Wang R,Liu Z,et al.XB130 expression in human osteosarcoma:a clinical and experimental study[J].Int J Clin Exp Pathol,2015,8(3):2565-2573.
9 Shi M,Zheng D,Sun L,et al.XB130 promotes proliferation and invasion of gastric cancer cells[J].J Transl Med,2014,12(1):1-11.
10 Li NY,Weber CE,Wai PY,et al.An MAPK-dependent pathway induces epithelial-mesenchymal transition via Twist activation in human breast cancer cell lines[J].Surgery,2013,154(2):404-410.
11 Shiozaki A,Shen G,Bai X,et al.XB130 mediates cancer cell proliferation and survival through multiple signaling events downstream of Akt[J].PLoS One,2012,7(8):e43646.
12 Otsuki S,Inokuchi M,Enjoji M,et al.Vimentin expression is associated with decreased survival in gastric cancer[J].Oncol Rep,2011,25(5):1235-1242.
13 Shiozaki A,Kosuga T,Ichikawa D,et al.XB130 as an independent prognostic factor in human esophageal squamous cell carcinoma[J].Ann Surg Oncol,2013,20(9):3140-3150.
14 Liu J,Hu Y,Hu W,et al.Expression and prognostic relevance of p21WAF1 in stage III esophageal squamous cell carcinoma[J].Dis Esophagus,2012,25(1):67-71.
15 Li J,Sun W,Wei H,et al.Expression of XB130 in human ductal breast cancer[J].Int J Clin Exp Pathol,2015,8(5):5300-5308.
16 Cunha IW,Carvalho KC,Martins WK,et al.Identification of genes associated with local aggressiveness and Metastatic behavior in soft tissue tumors[J].Transl Oncol,2010,3(1):23-32.
17 Zhang J,Jiang X,Zhang J.Prognostic significance of XB130 expression in surgically resected pancreatic ductal adenocarcinoma[J].World J Surg Oncol,2014,12(1):49-53.
18 Xu J,Bai XH,Lodyga M,et al.XB130,a novel adaptor protein for signal transduction[J].J Biol Chem,2007,282(22):16401-16412.
19 Zuo Q,Huang H,Shi M,et al.Multivariate analysis of several molecular markers and clinicopathological features in postoperative prognosis of hepatocellular carcinoma[J].Anat Rec(Hoboken),2012,295(3):423-431.

[1]	SUN Lichao,YANG Jing,SUN Lixin,ZHANG Yuan,YANG Zhihua,RAN Yuliang. Identification of monoclonal antibodies against hepatoma stem cells by screening for hepatoma spheroid cells [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 193-199.
[2]	ZHANG Jiawen,YU Yan,ZHANG Wei,CAO Jingyan,LUO Wen,SHANG Lihua. Serum metabolomics of small cell lung cancer patients based on UPLC-TOF/MS [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 200-205.
[3]	WANG Xiaoya,XIAO Bin,LIAO Yang,TANG Rongzhi,SUN Zhaohui,LI Linhai. Expression of CXCR family proteins in different subtypes of breast cancer and their clinical prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 206-210.
[4]	QIN Wen,ZHAO Nannan,HAN Yonghuan,XU Yajun. Expression of ZNF436 in gastric cancer and its effect on the migration and invasion of gastric cancer cells by WNT/β-catenin [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 222-227.
[5]	LIU Zhiqiang,CHU Yanjie,LIU Jing,WANG Yanbo. Atractylenolide I regulates proliferation and invasion of lung cancer A549 cells through the TLR4/MyD88 pathway [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 228-232.
[6]	LI Shuo,ZHANG Nannan,LI Liangliang,LONG Zhiping,YIN Huihui,ZHAO Yashuang,WANG Fan. Relationship between PDE4C gene methylation in peripheral blood leukocytes,interaction of environmental factors and pathogenesis of breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 233-238.
[7]	MENG Hai,DU Guanxiang,ZHU Liling,TANG Qiyun. The expression of WEE1 in gastric cancer and its influence on prognosis of patients [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 239-243.
[8]	LIU Jiayin,YAN Feihu,ZHANG Yanqiao. Genetic susceptibility of gastric cancer with single nucleotide polymorphisms(SNPs)of apoptotic genes - caspase-3 and caspase-7 [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 250-255.
[9]	ZHANG Yanqiu,HAN Ameng,LI Jinwang,GU Tao,FU Zhanzhao,MAO Yu,ZHANG Zijian,YANG Zhen. The preliminary study on clinical application of CRT+ARC technique in patients with locally advanced lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 256-260.
[10]	ZHU Lin,ZHANG Chunxia. Research progress of the nano drug-loading systems targeting tumor stem cells [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 276-279.
[11]	LI Shan,ZHAO Chunbo,QIAO Wenbo. Progress in the application of intraoperative radiotherapy in pancreatic cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 280-283.
[12]	CHEN Yanbo, KONG Dejia, ZHANG Jinfeng, MA Zhigang. Correlation between CYP2D6 gene polymorphism and tamoxifen metabolism in breast cancer patients [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 110-114.
[13]	LV Bowen, QIAN Jun, WANG Jie, QIAN Jingrong, LU Yingying, SU Liju, YANG Tongshu, LI Wenhui. Expression of MiR-455-5p in epithelial ovarian cancer and its target gene function [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 115-121.
[14]	SHI Xiaokang, DING Youming, WANG Bin, YU Bin, XU Yu. Expression and clinical significance of UBE2T in primary liver cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 128-133.
[15]	LIANG Hong, LI Qi, WANG Yaoxian, JIN Hong, WANG Tong, WANG Yanan, DUAN Yani, SONG Min. Interrupted time series trial for prevention of cardiovascular toxicity induced by chemotherapy in cervical cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 134-138.

Research of XB130,a novel adaptor protein in cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments